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A B S T R A C T
Background: Despite extensive knowledge of smoking eﬀects on respiratory disease, there is no study including
all age windows of exposure among ever smokers. The objective of this study was to assess the eﬀects from
smoking exposure in utero, early childhood, adolescence and adulthood on respiratory health outcomes in adult
male and female ever smokers.
Methods: Respiratory health outcomes were assessed in 10,610 participants of the European Community
Respiratory Health Survey (ECRHS) I who reported a history of ever smoking by questionnaire. The associations
of maternal smoking in utero, maternal smoking during childhood, age of smoking debut and pack-years of
smoking with respiratory symptoms, obstructive diseases and bronchial hyperreactivity were analysed using
generalized linear regression, non-linearity between age of smoking debut and outcomes were assessed by
Generalized additive mixed models.
Results: Respiratory symptoms and asthma were more frequent in adults if their mother smoked during preg-
nancy, and, in men, also if mother smoked in childhood. Wheeze and ≥3 respiratory symptoms declined with
later smoking debut among women [≤10 years: OR=3.51, 95% CI 1.26, 9.73; 11–12 years: 1.57[1.01–2.44];
13–15 years: 1.11[0.94–1.32] and ≤10 years: 3.74[1.56–8.83]; 11–12 years: 1.76[1.19–2.56]; 13–15 years:
1.12[0.94–1.35], respectively]. Eﬀects of increasing number of packyears were pronounced in women (Chronic
Obstructive Pulmonary Disease (COPD): OR/10 packyears women: 1.33 [1.18, 1.50], men: 1.14 [1.04, 1.26]
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pinteraction = 0.01).
Conclusions: Among ever smokers, smoking exposure in each stage of the lifespan show persistent harmful ef-
fects for adult respiratory health, while women appeared to be more vulnerable to an early age of smoking debut
and amount of smoking in adulthood.
1. Introduction
Smoking is the best documented hazard to respiratory health. While
smoking exposure and respiratory disease in adults have been studied
extensively, there is increasing interest in how exposure during other
critical age windows such as in utero, early childhood and adolescence
impact subsequent respiratory health. Both animal and epidemiological
studies suggest that exposure to smoking in utero or postnatally in-
creases the incidence of respiratory disease and related symptoms in
childhood (Martinez et al., 1992; Wu et al., 2012). There are less studies
analyzing early life smoking exposure eﬀects into adulthood; In a pre-
vious analysis of the European Community Respiratory Health Survey
(ECRHS) cohort we found that in utero and post-natal smoking exposure
was related to poorer adult respiratory health, while adjusting for adult
smoking (Svanes et al., 2004). We have also in this cohort found that
childhood disadvantage (including maternal smoking) was associated
with lower lung function, accelerated lung function and Chronic Ob-
structive Pulmonary Disease (COPD), in models adjusting for current
adult smoking (Svanes et al., 2004). However, tobacco smoking ex-
posure in early life is related to subsequent smoking habits, and the
inﬂuence of tobacco smoking on adult respiratory disease when con-
comitantly considering exposure through the life-span - in utero, in
childhood, in adolescence and adult pack-years - has not been pre-
viously elucidated.
There is only limited information as to how age of onset of smoking
inﬂuences subsequent respiratory health. Age of onset is relevant be-
cause exposure before the lungs are fully grown might have larger
consequences than for the fully developed lungs. One study showed that
early age smoking initiation was associated with a more rapid decline in
forced expiratory volume in 1 s (FEV1) (Apostol et al., 2002), and
childhood smoking as deﬁned by starting before age 16 years was
shown to be a strong risk factor for asthma in adults (Patel et al., 2004).
In these studies, non-smoking groups were used as reference category,
and early life exposure was not accounted for.
There are important sex diﬀerences in lung development and airway
behavior (Becklake and Kauﬀmann, 1999). Men have larger lungs in
childhood and adolescents (Carey et al., 2007), as well as in adulthood,
even when accounting for diﬀerences in age and height (Bellemare
et al., 2003). Our previous results indicated that in utero exposure to
tobacco smoking was more strongly associated with adult respiratory
health in women while post-natal exposure had larger impact in men
(Svanes et al., 2004). The respiratory health eﬀects from adult smoking
exposure also appear to be diﬀerent in men and women. For example,
the risk of COPD in one study was higher in women if they smoked
before the age of 16 years (Patel et al., 2004). The number of pack-years
is used as a measure of lifetime risk, with men smoking more and longer
over their lifetime (Prescott et al., 1997). The eﬀect of pack-years of
smoking on respiratory symptoms appeared to be higher in women than
men in two studies (Chinn et al., 2005; Langhammer et al., 2000), but
was not signiﬁcantly associated with lower FEV1 in women with COPD
in another study (Sorheim et al., 2010).
Thus, previous literature suggest that in addition to adult smoking,
exposure to tobacco smoking in utero and post-natal as well as age of
smoking debut in adolescence, are important for adult respiratory
health. Further, gender diﬀerences in vulnerability to smoking are
suggested both for early life and adult exposure. However, smoking
exposure in these diﬀerent time windows are inter-related, and eﬀects
of exposure in a speciﬁc age windows in previous studies may be
confounded by smoking in age windows not accounted for. In this study
we therefore aimed to investigate, comprehensively and in the same
models, the impact of tobacco smoking exposure in utero, postnatal, in
adolescence and in adulthood, for adult respiratory health (respiratory
symptoms, asthma, COPD and bronchial hyperresponsiveness) among
ever-smokers enrolled in the ECRHS 1. Only ever smokers were in-
cluded in order to promote the understanding of all vulnerable ex-
posure windows from early life to adult hood in this risk group. Only
ever smokers were included in this comprehensive analysis, in order to
determine the relative importance of each of the vulnerable exposure
windows from early life to adulthood, analysed in the same model and
in this risk group. There is a plethora of evidence to suggest that
smokers compared to non-smokers have a higher risk of asthma (Kumar
and Ram, 2017). Non-smokers as the reference group are studied
widely because the aim is to understand the role of “smoking” on re-
spiratory disease among smokers compared to non-smokers. Similarly,
evidence suggests that exposure to environmental tobacco smoke (ETS)
(including maternal smoking and exposure to smoking inside the home)
is associated with respiratory illness in children and adolescents
(Vanker et al., 2017). Again, in these studies the comparison group are
those not exposed to ETS. Therefore, we know that smoking is harmful
for respiratory health when comparing with a reference group of non-
smokers. However, the relative importance of early life smoking ex-
posure, the age of starting smoking as well as total pack-years of
smoking among ever-smokers is not known. In addition, we explored




The study population was recruited from 29 study centres in 14
countries and comprised adults aged 20–44 years who participated in
the European Community Respiratory Health Survey (ECRHS I), in-
itiated in 1991–1994. The protocols have been fully described else-
where and can be found at www.ecrhs.org. Brieﬂy, the ECRHS I in-
volved two stages. In the ﬁrst stage, random general population samples
were mailed a screening questionnaire, whereas in the second stage,
both a random general population sample and a symptomatic sample
were invited to participate in further clinical investigations, which in-
cluded a detailed structured interview including socio-demographic
factors, respiratory symptoms during the last 12 months as well as al-
lergic symptoms. In addition, clinical assessment of spirometric lung
indices was performed and anthropometric data were collected. The
present study included 10,610 adults (5348 men and 5262 women) who
reported to be current or former smokers in ECRHS I.
2.1.1. Deﬁnitions of outcome variables
2.1.1.1. Respiratory symptoms. Respiratory symptoms, current asthma
or allergy were obtained from questionnaires available at www.ecrhs.
org. “Wheeze” was deﬁned as wheezing or a whistling sound in the
chest in/during the last 12 months. The variable “≥3 respiratory
symptoms” was deﬁned as 3 or more of the following 8 symptoms in the
past 12 months: wheeze, wheeze with symptoms of breathlessness,
wheeze when not having a cold, waking up with tightness in chest,
woken by an attack of shortness of breath, woken by an attack of cough,
having had an attack of asthma or currently taking medicines for
asthma. “Chronic cough and phlegm” was deﬁned as cough or phlegm
for three months each year.
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2.1.1.2. Asthma, COPD and bronchial hyperresponsiveness
(BHR). “Current asthma” was deﬁned as an attack of asthma or use
of asthma medication in/during the last 12 months. “BHR”, a term
conﬁrming bronchial responsiveness to metacholine, was deﬁned as
presence of a 20% fall in forced expiratory volume. COPD was deﬁned
as a pre-bronchodilator forced expiratory volume in one second (FEV1)
divided by forced vital capacity (FVC) less than the lower limit of
normal (LLN). FEV1 and FVC were measured, and the best pulmonary
function curve was selected based on up to ﬁve technically acceptable
manoeuvres.
2.1.1.3. Atopy. Atopy was deﬁned as speciﬁc IgE against the following
allergens; house dust mites (Dermatophagoides pteronyssinus), cat
dander, timothy grass, and/or Cladosporium herbarum.
2.2. Smoking exposure variables
Smoking habits were recorded in the ECRHS I main questionnaire
and subjects were categorised as either ex-smokers (yes to question -
“Have you ever smoked for as long as year?”) or current smokers (yes,
to question – “Do you now smoke, as for one month ago?”).
Childhood and intrauterine exposure to smoking was deﬁned as a
positive response to the question, “Did your mother ever smoke reg-
ularly during your childhood, or before you were born?” Intrauterine
exposure was deﬁned as a positive response to the additional questions
“When your mother was pregnant, in particular with you, did she
smoke as usual during pregnancy?” and “Did she cut down or stop
during pregnancy?”
Age at smoking debut was determined based on the question “how
old were you when you started smoking?” It was coded both as a
continuous variable (age in years, in GAMM analyses), and categorised
in the following categories;≤10, 11–12, 13–15, 16–18 and 19 years or
more (logistic regression analyses). Pack-years smoked was constructed
based on questions regarding ever or current smoking, age at smoking
initiation, ever cutting down or stopped smoking and amount of
smoking at present or in the past.
2.3. Other variables
Paternal smoking exposure during childhood was based on the
question “Did your father ever smoke regularly during your child-
hood?”. Educational level was coded as a dichotomous variable deﬁned
as completion of full-time education. Exposure to passive smoking was
based on the question “Have you been exposed regularly to tobacco smoke
in the last 12 months?”. Anthropometric data was obtained during
clinical assessment.
2.3.1. Statistical methods
Separate generalized linear (logit link) regression models for men
and women were ﬁtted to all outcomes with a random eﬀect for centre
(Long and Freese, 2006). Age of smoking initiation were categorized as
≤10 years, 11–12 years, 13–15 years, 19 plus years with 16–18 years as
the reference age group. Maternal smoking in utero and postnatal and
pack-years of smoking were mutually adjusted in all models. All re-
gression models were adjusted for age, education level (Pekkanen et al.,
2005; Vittinghoﬀ et al., 2007), paternal smoking and passive exposure
to smoking. These variables were retained in the models if they were
signiﬁcant at the 5% level of signiﬁcance or they changed the estimated
eﬀects by more than 10%.
Interactions between sex and smoking exposures were tested and p
value< 0.1 considered statistically signiﬁcant to avoid missing any
important interactions. Data were further stratiﬁed by ex/current
smokers and interactions tested. Additional sensitivity analysis (where
required) were conducted by adjusting for current smoking. All results
in the logistic regression analyses tables are presented as odds ratios
(OR) and 95% conﬁdence intervals (CIs). These analyses were per-
formed using Stata release 12.1 (College Station, Texas).
To explore whether associations between age of smoking debut (as a
continuous variable) and respiratory outcomes were nonlinear we ﬁtted
generalized additive mixed models to account for the study centre
(GAMM) (Altman, 1990; Hastie and Tibshirani, 1986) separately for
males and females using the the MGCV 1.8–3 package (Wood, 2013) in
R (Version 3.1.0) (R Core Team, 2015). A similar approach to the
Generalized Linear modelling was adopted for the GAMMS. We ﬁtted
GAMMS to all outcomes to examine any non-linear associations with
age of smoking debut. If non-linearity was present we ﬁtted sex and age
of smoking debut interaction terms and present results separately by
men and women if these interaction terms were signiﬁcant at p < 0.1.
The non-linear associations between age of smoking debut and
outcomes by men and women are presented in graphical format. The x-
axis is deﬁned as age of smoking debut (continuous) with cubic spline
curves ﬁtted versus age of smoking debut. The 95% CI are also shown. A
probability density graph for the age of smoking debut is also plotted on
each graph.
3. Results
Table 1 shows selected characteristics of the ECRHS study partici-
pants by gender. Men generally started smoking at a younger age (mean
age of smoking debut 16.6 years, standard deviation (SD)= 3.3) than
women (17.2 years, SD=3.3) p < 0.001, and had smoked a larger
number of pack-years than women (mean=16.2, SD=14.4, and
mean=11.2, SD=10.6 respectively), p < 0.001. Prevalence of re-
spiratory symptoms and outcomes by age of smoking debut for men and
women are displayed in the online supplement (Supplementary
Table 1).
In women, exposure to maternal smoking in utero was associated
with a greater risk of wheeze, wheeze without a cold, chest tightness,
nocturnal cough, more than three respiratory symptoms and current
asthma (Table 2A). Associations with postnatal maternal smoke
Table 1
Selected characteristics of the study population.
Overall N= 10,553a Men N=5348= (50.41) Women N=5262 (49.59)
Ex smokers 3.730 (35.35) 1796 (33.77) 1934 (36.95)
Age of exsmokers, mean (SD) 36 (6.54) 36.60 (6.52) 35.44 (6.51)
Current smokers 6823 (64.65) 3523 (66.23) 3300 (63.05)
Age of current smokers, mean (SD) 33.57 (7.01) 33.77 (7.09) 33.35 (6.92)
Morther smoked in childhood 1778 (17.23) 907 (17.47) 871 (16.98)
Father smoked in childhood 7076 (70.75) 3599 (71.20) 3477 (70.30)
Maternal smoke in utero 1029 (9.97) 401 (7.72) 628 (12.24)
Age of smoking debut mean (SD) 16.9 (3.3) 16.6 (3.3) 17.2 (3.3)
Pack years median (25th%, 75th%) 10 (4.5, 19) 12.5 (6, 22.5) 8.2 (3.5, 15.75)
Did not complete full time education 1383 (13.03) 737 (13.78) 646 (12.28)
Data presented as number (%).
a Total of Ex and current smokers.
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exposure were signiﬁcant only for current asthma. Associations of early
life exposure and COPD did not reach statistical signiﬁcance. Compared
to age of smoking debut at 16 years of age, early age of smoking debut
was associated with wheeze and wheeze with symptoms of breath-
lessness but not BHR alone. Smoking debut less than 10 years of age
alone was associated with higher odds of chest tightness, atopy and
current asthma. Pack-years of smoking were signiﬁcantly associated
with all respiratory outcomes, but not with current asthma.
Among men, exposure both to maternal smoking in utero and post-
natal were strongly associated with increased risk of respiratory
symptoms and asthma but not COPD (Table 2B). Compared to women,
the early life impact seemed more consistent for men, in particular the
impact of postnatal exposure. Onset of smoking at ages 11–12 in men
was associated with wheeze, wheeze without a cold, chest tightness,
nocturnal breathlessness, but not asthma and COPD than age of
smoking debut at age 16–18 years (Table 2B). Similar to women, age of
smoking debut wasn’t associated with current asthma or COPD. Further
adjustment of all regression models by exposure to passive environ-
mental tobacco smoke and current adult smoking did not change the
observed eﬀects by more than 10% or were not signiﬁcant when en-
tered into the models.
Interaction terms between sex and smoking exposures were ﬁtted
using the Generalized Linear Models (Supplementary Table 2). In this
table we present regression models for men and women combined and
present the p value for the interaction term between sex and the
smoking exposure in parentheses for each outcome analysis. The eﬀects
of maternal smoking in utero appeared to be slightly stronger among
men (wheeze with symptoms of breathlessness: p interaction = 0.07
term). The eﬀects of earlier age of smoking debut were signiﬁcantly
stronger among women than among men for most outcomes
(Supplementary Table 2 p values for interactions in parentheses).
Considering interaction by sex for age of smoking debut as a con-
tinuous variable, the non-linear associations between age of smoking
debut and wheeze and more than three symptoms were signiﬁcantly
diﬀerent for men and women, women being more vulnerable to early
smoking debut (pinteraction = 0.002 and 0.02 respectively). Figs. 1 and 2
shows the GAMMS ﬁt for age of smoking debut as a continuous vari-
able, for wheeze and for≥3 symptoms, separately for men and women.
For all other outcomes, non-linear associations were not observed and
hence GAMMs were not presented as the eﬀects from the Generalized
Linear Models suﬃced.
As a sensitivity analysis, we stratiﬁed the data by ex-smoker and
current smokers separately for men and women. Among women
(Supplementary Table 3a and 3b) the eﬀects of maternal smoking in
utero and postnatal seem to be consistent between ex and current
smokers. The observed eﬀect of age of smoking debut, more than three
symptoms, atopy and current asthma were only signiﬁcant in current
smokers. In men (Supplementary Table 3c and 3d) the eﬀects of ma-
ternal smoking maternal smoking in utero and postnatal seem to be
consistent between ex and current smokers, although for some outcome
variables the estimated eﬀects failed to reach statistical signiﬁcance
among ex-smokers. The observed eﬀects for age of smoking debut when
stratiﬁed by ex and current smokers were generally similar. Other ob-
served eﬀects were generally similar as in the combined group
(Table 2A and 2B) but failed to reach statistical signiﬁcance in smaller
subgroups (Supplementary Table 3c and 3d).
4. Discussion
Our comprehensive analysis of ever smokers, incorporating smoking
Table 2A
Respiratory symptoms and health outcomes in women as related to time windows of smoking exposure through the lifespan.
Respiratory outcomes Age started smoking OR 95% CI
Maternal smoking In
utero OR 95% CI
Maternal smoking
Postnatally OR 95% CI
≤ 10 11–12 13–15 16–18 19+ Pack years per year
OR 95% CI
Wheeze 1.51 1.14 3.51 1.57 1.11 Ref 1.04 1.04
1.24, 1.86*** 0.97, 1.32 1.26, 9.73* 1.01,
2.44*
0.94, 1.32 0.89, 1.22 1.07, 1.92*
Wheeze with symptoms of
breathlessness
1.25 1.14 3.84 1.82 1.21 Ref 1.01 1.02
0.94, 1.66 0.91, 1.45 1.38, 10.64** 1.19,
2.76**
1.02, 1.43* 0.85, 1.19 1.01, 1.04***
Wheeze without having a cold 1.46 1.16 1.88 1.47 1.10 Ref 1.06 1.04
1.21, 1.79** 0.96, 1.41 0.64, 5.55 0.94, 2.23 0.91, 1.34 0.92, 1.22 1.02, 1.045***
Chest tightness 1.31 1.001 2.59 1.32 1.14 Ref 1.18 1.02
1.01, 1.69* 0.82, 1.23 1.11, 6.07* 0.88, 1.97 0.94, 1.37 1.02,
1.39*
1.01, 1.03***
Nocturnal breathlessness 0.99 0.98 2.38 1.15 0.95 Ref 1.32 1.02
0.72, 1.32 0.72, 1.32 0.82, 6.96 0.61, 2.18 0.76, 1.23 1.11,
1.59**
1.01, 1.03**
Nocturnal cough 1.35 1.11 2.76 0.93 0.93 Ref 1.15 1.02
1.11, 1.63** 0.95, 1.31 0.94,8.13 0.69, 1.24 0.81, 1.07 0.99, 1.34 1.01, 1.03***
Morning cough 1.15 0.98 1.37 0.73 0.96 Ref 1.25 1.06
0.91, 1.417 0.77, 1.24 0.62, 3.01 0.46, 1.14 0.79, 1.15 0.99, 1.57 1.04, 1.07***
≥3 respiratory symptoms 1.51 1.14 3.74 1.76 1.12 Ref 1.13 1.03
1.21, 1.89*** 0.95, 1.36 1.56, 8.83** 1.19,
2.56**
0.94, 1.35 0.94, 1.37 1.02, 1.04***
Atopy 1.07 1.18 3.76 0.97 0.94 Ref 0.86 0.99
0.82, 1.42 0.94, 1.47 1.18, 11.97* 0.65, 1.44 0.77, 1.13 0.72, 1.02 0.98, 1.01
BHR 1.18 1.25 1.22 1.01 0.99 Ref 1.15 1.02
0.86, 1.61 0.98, 1.57 0.31, 4.71 0.52, 1.92 0.77, 1.26 0.98, 1.36 1.01, 1.03***
Current asthma 1.4 1.48 4.32 1.85 1.07 Ref 0.87 0.99
1.14, 1.75** 1.06, 2.06** 1.87, 9.96** 0.97, 3.56 0.81, 1.39 0.62, 1.21 0.98, 1.01
COPD 1.01 1.21 1.06 1.18 1.13 Ref 1.28 1.03
0.55, 1.82 0.87, 1.67 0.28, 3.95 0.56, 2.53 0.76, 1.65 0.89, 1.86 1.02, 1.05***
All models adjusted for age, pack-years, maternal and paternal smoking, educational level and centre.
* Signiﬁcant at 0.05 level.
** Signiﬁcant at 0.01 level.
*** Signiﬁcant< 0.001.
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exposure in early life, adolescence and adulthood in the same models,
shows important impacts of exposure in each time window for re-
spiratory symptoms and asthma, in both men and women. With regard
to COPD, amount of adult exposure in terms of pack-years of smoking
picked up the major part of the eﬀects. There appeared to be diﬀerences
between men and women in response to exposure at the diﬀerent time
windows: Generally, the eﬀects of early life exposure on respiratory
symptoms seemed slightly more consistent in men while the eﬀects of
early smoking debut and per pack-year were signiﬁcantly stronger
among women.
To our knowledge, there are not previous studies concomitantly
accounting for exposure in utero, post-natal, adolescence and adult-
hood. It is well understood that smoking during the adult lifespan is a
key contributor to respiratory disease. Although extensively studied in
children, data on maternal smoking in utero and respiratory disease in
adults are limited. Our ﬁndings are similar to a study by Skorge et al.
(Skorge et al., 2005) reporting signiﬁcant associations between ma-
ternal smoking in utero and incidence of asthma and respiratory
symptoms in adults from a community based cohort aged between 15
and 70 years. They also reported increased odds of wheeze with both
pre- and postnatal exposure combined. An earlier cohort study of early
life risk factors, asthma and wheezing in adults followed until age 33
Table 2B
Respiratory symptoms and health outcomes in men as related to time windows of smoking exposure through the lifespan.
Respiratory outcomes Age started smoking OR 95% CI
Maternal smoking In
utero OR 95% CI
Maternal smoking
Postnatally OR 95% CI
≤10 11–12 13–15 16–18 19+ Pack years per year
OR 95% CI
Wheeze 1.52 1.18 0.88 1.38 1.11 Ref 1.14 1.02
1.16, 1.99** 0.97, 1.42 0.64, 1.22 1.03, 1.84* 0.94, 1.31 0.94, 1.39 1.01, 1.03***
Wheeze with symptoms of
breathlessness
1.83 1.32 0.99 1.35 1.11 Ref 1.01 1.01
1.44, 2.31*** 1.03, 1.68* 0.65, 1.52 0.96, 1.89 0.89, 1.40 0.79, 1.29 0.99, 1.02
Wheeze without having a cold 1.41 1.21 1.13 1.38 1.08 Ref 1.09 1.02
1.11, 1.79** 1.02, 1.42* 0.72, 1.76 1.06, 1.79* 0.87, 1.34 0.87, 1.38 1.01, 1.03***
Chest tightness 1.4 1.04 1.61 1.33 1.14 Ref 1.08 1.01
1.03, 1.89* 0.86, 1.26 1.09,
2.36*
1.03, 1.73* 0.93, 1.42 0.83, 1.40 1.002, 1.02***
Nocturnal breathlessness 0.94 0.72 1.66 1.67 1.28 Ref 1.64 1.003









Nocturnal cough 1.19 0.99 1.03 0.97 0.89 Ref 1.05 1.02
0.94, 1.51 0.82, 1.19 0.62, 1.71 0.68, 1.39 0.75, 1.07 0.89, 1.26 1.01, 1.03***
Morning cough 0.96 0.86 0.69 1.27 0.98 Ref 1.05 1.04
0.71, 1.31 0.71, 1.07 0.39, 1.22 0.88, 1.81 0.83, 1.18 0.85, 1.31 1.03, 1.05***
≥3 respiratory symptoms 1.53 1.24 1.17 1.30 1.14 Ref 1.16 1.02
1.19, 1.96** 1.01, 1.52* 0.82, 1.67 1.02, 1.66* 0.92, 1.42 0.92, 1.46 1.008, 1.03***
Atopy 1.09 1.16 0.62 1.10 0.82 Ref 0.86 0.99
0.83, 1.44 0.97, 1.38 0.4, 0.95* 0.79, 1.54 0.71,
0.94**
0.74, 1.00 0.98, 0.999**
BHR 1.25 1.01 0.84 1.31 1.22 Ref 0.86 1.006
0.82, 1.92 0.78, 1.29 0.48, 1.49 0.81, 2.13 1.01,
1.46*
0.66, 1.14 0.99, 1.02
Current asthma 1.76 1.62 1.001 1.22 1.12 Ref 1.002 0.97, 0.95, 0.98***
1.04, 2.95* 1.26, 2.09** 0.46, 2.15 0.62, 2.46 0.77, 1.62 0.72, 1.43
COPD 1.06 1.51 0.45 1.14 1.28 Ref 0.68 1.011
0.59, 1.87 0.96, 2.34 0.17, 1.21 0.59, 2.22 0.81, 2.04 0.45, 1.03 1.001, 1.03*
All models adjusted for age, pack-years, maternal and paternal smoking, educational level and centre.
* Signiﬁcant at 0.05 level.
** Signiﬁcant at 0.01 level.
*** Signiﬁcant< 0.001.
Fig. 1. Nonlinear eﬀects of age of smoking debut as a continuous variable and wheeze separately by men and women.
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years, found that both smoking during pregnancy and starting smoking
at 16 years of age was a strong predictor of wheeze in adults (Strachan
et al., 1996). This study did not examine diﬀerences between men and
women nor assessed eﬀects concomitantly.
Studies focusing on age of smoking debut and respiratory disease in
adults are rare. In our study mean age of onset of smoking in men and
women are similar to other studies (Clennell et al., 2008; Patel et al.,
2004; Vianna et al., 2008). Patel and colleagues (Patel et al., 2004)
reported increased odds of asthma in women who started smoking in
childhood deﬁned as less than 16 years of age but not in men. Although
we ﬁnd similar results for women too, our ﬁndings are not directly
comparable as they ﬁtted separate models for current and ex-smokers
while we combined current/ex smokers in all our analysis. Besides, the
study by Vianna and colleagues (Vianna et al., 2008) did not report
ﬁndings by age of onset of smoking and respiratory outcomes although
they used the Brazil sample from ECRHS. Moreover, neither of these
studies examined the association between age of smoking onset and
respiratory outcomes whilst mutually adjusting for early life exposure
to smoking and pack-years separately by men and women. In our study,
women were more vulnerable to early age of smoking debut than men,
in models accounting for gender diﬀerences in all exposure periods.
Our ﬁndings of increasing risk for respiratory symptoms with higher
tobacco exposure (in our study measured as number of pack-years), are
consistent with a large Norwegian population based study
(Langhammer et al., 2000). In this study the odds of current asthma and
wheeze in adults increased with the number of daily cigarettes, and in
agreement with our results, the risk related to increasing exposure was
greater in women than in men. Also a study of young adults in Brazil
reported increase in odds of respiratory symptoms with increasing
numbers of cigarettes smoked per day (Oliveira et al., 2008). The in-
verse association observed for pack-years and asthma and only slightly
lower odds for men is intriguing. Smoking may be a determinant for
diagnosing respiratory symptoms as asthma or not, thus, the ﬁnding is
likely to be explained by diagnostic bias. The results on symptoms are
more reliable in this context.
Although other studies using ECRHS data have examined various
smoking exposure windows and respiratory outcomes (Milenkovic
et al., 2011; Urrutia et al., 2005), no previous analysis has examined
comprehensively respiratory health eﬀects of tobacco exposure over the
life course, including all exposure windows in the same models. This
might explain why a previous analysis suggested that in utero exposure
had stronger eﬀects in women while the current analysis indicates
slightly more convincing early life eﬀects on respiratory health among
men (Svanes et al., 2004). Previous analyses of early life exposure have
not accounted for potential gender-speciﬁc confounding i.e. by ado-
lescent smoking. The discrepancy might possibly also be related to the
fact that the current analysis only included ever-smokers; i.e. if in utero
exposure was particularly harmful in never-smoking women. The cur-
rent results are, however, in agreement with the previous analysis
(Svanes et al., 2004) concerning eﬀects of post-natal smoking being
more convincing among men.
We included education level as a priori in all models as this variable
has been shown to be a major confounder in smoking exposure asso-
ciations. This variable is a good marker of socio-economic status and to
some extent also reﬂects air pollution (as lower SES are often located in
high pollution/less green space areas). We do not have birth weight
data for the full cohort, and it has been shown that in utero smoking
exposure eﬀects were independent of birth weight on the development
of the respiratory system (Hoo et al., 1998). Additional variables would
contribute to over adjustment of models.
This study has a number of strengths. Although the design was
cross-sectional, the large ECRHS I cohort design enabled analysis of
diﬀerences by men and women with suﬃcient power to detect asso-
ciations between exposures and outcomes. The participants included in
this study are a large subsample of the full cohort in ECRHS in Phase I.
ECRHS is an international cohort with each included centre a re-
presentative sample of the general population within that region and
although there may be heterogeneity between regions, we used ap-
propriate statistical methodology to accommodate for these possible
diﬀerences. Self-reported symptoms are collected through a validated
international questionnaire and although there was some variation of
prevalence of reported respiratory symptoms between countries, a va-
lidation study showed good internal consistency suggesting that
country speciﬁc characteristics are unlikely to impact on self reporting
of respiratory symptoms (Janson et al., 2001). Because we have com-
bined current smokers and ex-smokers we have conﬁdence in our cal-
culation of pack-years, because recall bias may be an issue when esti-
mating smoking, especially among ex-smokers (Vold et al., 2014).
A number of limitations do need to be acknowledged when inter-
preting our ﬁndings. Only prebronchodilator spirometry was measured
and as such should be considered as a limitation when assessing ex-
posure outcome associations for COPD. By restricting our study base to
ever-smokers we do not understand these associations for the group
who were only exposed to maternal smoking during pregnancy or
postnatal, but were never smoking themselves and therefore strictly do
not cover all aspects of lifetime exposure to tobacco smoke. Healthy
smoking bias is also a possibility. Smokers without symptoms may
continue to smoke and those that quit early possibly because they ex-
perience respiratory symptoms and then subsequent asthma diagnosis
(ex-smokers). The pool of current smokers over time may include those
who have had few respiratory symptoms and so the current smokers are
“healthier” and less likely to develop asthma and mask the true
Fig. 2. Nonlinear eﬀects of age of smoking debut as a continuous variable and more than 3 symptoms separately by men and women.
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association between smoking exposures and respiratory outcomes.
Most epidemiological studies use self report data on smoking and
recall bias can be an issue. Women who are current smokers are less
likely to report smoking (Shipton et al., 2009). However, a study of the
agreement between nicotine levels and self report smokers reported
93% agreement for women and 92% agreement for men in an adult
population in the United States (Caraballo et al., 2001). Although ma-
ternal smoking questions were not validated in ECRHS, recall bias may
be limited as Svanes et al. (2004) showed that there were little diﬀer-
ence in how symptomatic and non-symptomatic participants responded
to questions regarding parental smoking. Nevertheless, self-reported
data on smoking may not be completely accurate and therefore may
lead to conservative estimates of the eﬀects of smoking. Self report
childhood exposure to environmental smoking in adults may also be
susceptible to diﬀerential bias. Our data on adult smoking and pack-
years is much better than the data on early life exposure as the latter are
crude and do not include information about the amount of exposure. By
including them all in one model it is possible that we are under-
estimating the early life eﬀects. However, investigating all exposures
concurrently is important and a major strength of this study.
In summary, smoking exposure in each stage of the lifespan showed
persistent harmful eﬀects with regard to adult respiratory health. The
impact of early life exposure appeared to be somewhat more consistent
in men than in women, while women appeared to be more vulnerable to
an early age of smoking debut and a large amount of adult exposure.
Our ﬁndings reinforce the notion that there are several critical windows
of exposure that are all of importance, even in mutually adjusted ana-
lytical models. Basic research should explore the mechanisms for
gender diﬀerences in eﬀects of tobacco smoke exposure during diﬀerent
critical age windows.
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